TME Pharma N.V. (EPA:ALTME)
France · Delayed Price · Currency is EUR 0.0630
+0.0004 (0.64%)
Aug 3, 2026, 2:38 PM CET
TME Pharma Market Cap
TME Pharma has a market cap or net worth of €5.89 million as of August 3, 2026. Its market cap has decreased by -43.11% in one year.
Market Cap
5.89M
Enterprise Value
6.27M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.06
ChartMarket Cap Chart
Since September 30, 2016, TME Pharma's market cap has decreased from 43.13M to 5.89M, a decrease of -86.34%. That is a compound annual growth rate of -18.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 5.89M | -3.99% |
| Dec 31, 2025 | 6.13M | -13.10% |
| Dec 31, 2024 | 7.06M | 478.85% |
| Dec 29, 2023 | 1.22M | -26.24% |
| Dec 30, 2022 | 1.65M | -90.52% |
| Dec 31, 2021 | 17.44M | -28.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Advicenne | 23.86M |
| genOway Société anonyme | 22.50M |
| GenSight Biologics | 19.13M |
| Aelis Farma | 13.92M |
| Poxel | 11.26M |
| NFL Biosciences | 11.02M |
| Aton | 8.45M |
| Oncodesign Precision Medicine Société anonyme | 6.13M |